The timing of HFOV initiation and the expertise of the personnel may have implications. No relationship between the number of patients studied per site and mortality. The authors report no further potential conflict of interest.
The timing of HFOV initiation and the expertise of the personnel may have implications. No relationship between the number of patients studied per site and mortality. The authors report no further potential conflict of interest.
The timing of HFOV initiation and the expertise of the personnel may have implications. No relationship between the number of patients studied per site and mortality. The authors report no further potential conflict of interest.
2234 have important implications. For example, in the OSCAR study, severity of illness was calculated on admission, whereas we used data obtained 24 hours before randomization, which may have resulted in systematic differences in scores on the Acute Physiology and Chronic Health Evaluation (APACHE) II between the studies. As Muellenbach and colleagues point out, both the timing of HFOV initiation and the expertise of the personnel using the device may have im- portant implications. We specified that patients be enrolled within 72 hours after meeting study inclusion criteria, and we enlisted centers in which there was substantial experience in using HFOV. Although we cannot attest to the exper- tise of every clinician who cared for patients in the trial, we found no relationship between the number of patients studied per site (as a rough measure of experience) and mortality. Niall D. Ferguson, M.D. Arthur S. Slutsky, M.D. University of Toronto Toronto, ON, Canada Maureen O. Meade, M.D. McMaster University Hamilton, ON, Canada meadema@hhsc.ca Since publication of their article, the authors report no fur- ther potential conflict of interest. 1. Fessler HE, Derdak S, Ferguson ND, et al. A protocol for high-frequency oscillatory ventilation in adults: results from a roundtable discussion. Crit Care Med 2007;35:1649-54. 2. Guervilly C, Forel JM, Hraiech S, et al. Right ventricular function during high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome. Crit Care Med 2012;40: 1539-45. 3. Mehta S, Burry L, Cook D, et al. Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. JAMA 2012; 308:1985-92. [Erratum, JAMA 2013;309:237.] DOI: 10.1056/NEJMc1304344 Dr. Young replies: MacDuff and Holland sug- gest that the lower mortality in the OSCILLATE control group, which they attribute to the use of smaller tidal volumes in conventional ventilation than were used the OSCAR study, may have un- masked the harm that HFOV was causing. This may be the case, although there might also have been differences between the two control groups that were not captured in the severity scores, demographic characteristics, or other recorded data that would account for the differences. In the OSCAR study, we spent a considerable amount of time training participating critical care staff in the use of HFOV. It would not have been appropriate to introduce a new mechanical ventilator to critical care units without this training, whether in the context of a trial or not. In clinical trials of interventions that require training, it is not uncommon to look at the results to see whether the effect size changes as units recruit more patients, suggesting a learning ef- fect. We are currently looking into this issue. Guervilly and colleagues suggest that in the OSCILLATE study, the higher mean airway pres- sure in the HFOV group than in the control group may account for the increased early use of vasoactive drugs in this group. In the OSCAR study, the mean pressure was not recorded in the control group, so we cannot determine whether it was the same as that in the HFOV group. There was no significant between-group difference in the use of vasoactive drugs in the OSCAR study, as recorded as the proportion of patients receiv- ing these drugs. Duncan Young, D.M. John Radcliffe Hospital Oxford, United Kingdom Since publication of his article, the author reports no further potential conflict of interest. DOI: 10.1056/NEJMc1304344 Myths, Presumptions, and Facts about Obesity To the Editor: Casazza et al. (Jan. 31 issue) 1
state that the common notion that regularly eating (versus skipping) breakfast is protective against obesity because people who skip break- fast may overeat later in the day is currently noth- ing more than a presumption. However, the evi- dence they cite in support of this statement is more complex than they intimate. Examination of this evidence implies overcompensation (with increased food consumption later in the day after having skipped breakfast), but also undercom- pensation depending on timing of meals. 2,3 In addition, Casazza and colleagues do not ac- knowledge the short-term nature of the available experimental research on which they focus exclu- sively. Several surveys and a longitudinal study have negatively correlated body-mass index (BMI) with the frequency of eating breakfast, and mul- The New England Journal of Medicine Downloaded from nejm.org on August 4, 2014. For personal use only. No other uses without permission. Copyright 2013 Massachusetts Medical Society. All rights reserved. correspondence n engl j med 368;23 nejm.org june 6, 2013 2235 tiple studies indicate that a greater proportion of daily consumption of calories earlier in the day is related to being slim. 3-5 Although Casazza et al. have initiated a helpful discussion on the impor- tant and topical issue of the role of breakfast and other presumptive factors in weight control such as weight cycling and snacking, their treatment of the existing literature is not representative of the present evidence about the timing of meals and its effect on body weight. Jrg W. Huber, Ph.D. University of Northampton Northampton, United Kingdom jorg.huber@northampton.ac.uk Lewis G. Halsey, Ph.D. Sue Reeves, Ph.D. University of Roehampton London, United Kingdom Drs. Huber, Halsey, and Reeves report receiving grant support from Kelloggs. No other potential conflict of interest relevant to this letter was reported. 1. Casazza K, Fontaine KR, Astrup A, et al. Myths, presump- tions, and facts about obesity. N Engl J Med 2013;368:446-54. 2. Halsey LG, Huber JW, Low T, Ibeawuchi C, Woodruff P, Reeves S. Does consuming breakfast influence activity levels? An experiment into the effect of breakfast consumption on eat- ing habits and energy expenditure. Public Health Nutr 2012; 15:238-45. 3. Garaulet M, Gmez-Abelln P, Alburquerque-Bjar JJ, Lee YC, Ordovs JM, Scheer FA. Timing of food intake predicts weight loss effectiveness. Int J Obes (Lond) 2013;37:624. 4. Rampersaud GC, Pereira MA, Girard BL, Adams J, Metzl JD. Breakfast habits, nutritional status, body weight, and academic performance in children and adolescents. J Am Diet Assoc 2005;105:743-60. 5. Timlin MT, Pereira MA, Story M, Neumark-Sztainer D. Breakfast eating and weight change in a 5-year prospective analysis of adolescents: Project EAT (Eating Among Teens). Pe- diatrics 2008;121(3):e638-e645. DOI: 10.1056/NEJMc1303009 To the Editor: It is troubling that breast-feeding was included in Myths, Presumptions, and Facts about Obesity. The supporting evidence was limited and included only three articles: a review by two of the same authors, 1 an incorrectly de- scribed study, 2 and a commentary. Oddly, the au- thors previous review 1 states a definitive con- clusion of no protective effect of breast-feeding on obesity is premature, and more research is needed. The incorrect citation to one article by Kramer and colleagues referred to a cluster-ran- domized trial of an intervention to promote breast-feeding in Belarus; that trial evaluated in- fants behavior, not obesity. 2 The presumed cor- rect reference indicates that there was less over- weight and obesity in Belarus than in the United States, 3 but the trial did not adjust for sex; this was an oversight given the dichotomized preva- lence of obesity among adults (16% of Belarusian men and 32% of Belarusian women are obese). Furthermore, recent data 4 show that breast-feed- ing is associated with a lower BMI in infancy and a slower growth trajectory in childhood. Other provocative research suggests bioactive substanc- es in breast milk may have a protective influence on metabolic programming and infant growth. 5
It is irresponsible to say conclusively that breast- feeding is protective against obesity is a myth without reviewing all the evidence. Enette Larson-Meyer, Ph.D., R.D. Ann Marie Hart, Ph.D., F.N.P. Brenda Alexander, Ph.D. University of Wyoming Laramie, WY enette@uwyo.edu No potential conflict of interest relevant to this letter was re- ported. 1. Casazza K, Fernandez JR, Allison DB. Modest protective ef- fects of breast-feeding on obesity. Nutr Today 2012;47:33-8. 2. Kramer MS, Fombonne E, Igumnov S, et al. Effects of pro- longed and exclusive breastfeeding on child behavior and mater- nal adjustment: evidence from a large, randomized trial. Pediat- rics 2008;121(3):e435-e440. 3. Kramer MS, Matush L, Vanilovich I, et al. A randomized breast-feeding promotion intervention did not reduce child obe- sity in Belarus. J Nutr 2009;139:417S-4521S. 4. Crume TL, Ogden LG, Mayer-Davis EJ, et al. The impact of neonatal breast-feeding on growth trajectories of youth exposed and unexposed to diabetes in utero: the EPOCH Study. Int J Obes (Lond) 2012;36:529-34. 5. Savino F, Fissore MF, Liguori SA, Oggero R. Can hormones contained in mothers milk account for the beneficial effect of breast-feeding on obesity in children? Clin Endocrinol (Oxf) 2009;71:757-65. DOI: 10.1056/NEJMc1303009 To the Editor: Casazza and colleagues describe seven myths about obesity that persist, contrary to refuting evidence. One of these myths is that physical education, in its current form, plays an important role in reducing or preventing obesity. What the authors do not consider is the high de- gree of variability in existing physical-education programs and that although some may not be efficacious, others provide evidence to the con- trary. This is particularly surprising given that in a major position paper by one of the authors and others, 1 evidence is highlighted from several studies that show improvements in physical ac- tivity 2 and reduction in obesity 3 associated with school physical-education programs. One should certainly recognize that some schools do not de- vote sufficient time to physical education 1 and that some programs may be ineffectual. How- The New England Journal of Medicine Downloaded from nejm.org on August 4, 2014. For personal use only. No other uses without permission. Copyright 2013 Massachusetts Medical Society. All rights reserved. The new engl and journal o f medicine n engl j med 368;23 nejm.org june 6, 2013 2236 ever, to suggest that physical education does not act as a salient context for the prevention of obe- sity is not only irresponsible from a public health perspective, but it also fails to recognize the val- ue of understanding moderating variables (e.g., the composition of physical-education programs and adherence of schools to recommended guide- lines for weekly physical-education classes) that may explain the conditions under which physical education can be successful. Mark R. Beauchamp, Ph.D. University of British Columbia Vancouver, BC, Canada mark.beauchamp@ubc.ca No potential conflict of interest relevant to this letter was re- ported. 1. Pate RR, Davis MG, Robinson TN, Stone EJ, McKenzie TL, Young JC. Promoting physical activity in children and youth: a leadership role for schools: a scientific statement from the American Heart Association Council on Nutrition, Physical Ac- tivity, and Metabolism (Physical Activity Committee) in collabo- ration with the Councils on Cardiovascular Disease in the Young and Cardiovascular Nursing. Circulation 2006;114:1214-24. 2. Pate RR, Ward DS, Saunders RP, Felton G, Dishman RK, Dowda M. Promotion of physical activity in high-school girls: a randomized controlled trial. Am J Public Health 2005;95:1582-7. 3. Gortmaker SL, Peterson K, Wiecha J, et al. Reducing obesity via a school-based interdisciplinary intervention among youth: Planet Health. Arch Pediatr Adolesc Med 1999;153:409-18. DOI: 10.1056/NEJMc1303009 The Authors Reply: Our article aimed to inspire a dialogue on obesity research. We are pleased that it has. Several writers commented that we did not cite all pertinent studies. As we stated in our article, references to published studies are used spar- ingly herein. Because of strict Journal limits on references, we included only the most informa- tive evidence. Huber et al. note complexities in the litera- ture regarding breakfast consumption and obe- sity. We agree. None of this alters our conclusion regarding breakfast consumption. We are cur- rently testing the breakfast hypothesis in a randomized, controlled trial (ClinicalTrials.gov number, NCT01781780). Larson-Meyer et al. question our conclusion regarding breast-feeding and obesity. We apolo- gize that one of our citations 1 (reference 16 in the article) was an error and should have been a reference to another article by Kramer et al. 2
However, our description of the data was correct. The one large, randomized, controlled trial con- ducted showed no effect. Although association studies suggest a possible benefit, these studies show no association once infants reach adult- hood, are not probative for causation, and have confounding and publication bias. 3 Larson-Meyer et al. state provocative research suggests bioac- tive substances in breast milk may have a protec- tive influence. Yes, but provocative research is not probative research. Larson-Meyer et al. quote our earlier statement that results were incon- clusive. However, since our earlier writing, no supportive randomized, controlled trials have emerged, and findings from studies that refute the association have materialized. 4 These chang- es lead us now to categorize this belief as a myth. Moreover, since our recent article was published, data from an additional randomized, controlled trial 5 have emerged that further re- fute the breast-feeding hypothesis. Beauchamp notes high variability in physical- education programs and their reported efficacy. Indeed, physical-education programs can vary widely and may increase physical activity, im- prove fitness, and have other benefits. But there is no consistent evidence that forms of physical education that are commonly used in schools prevent or reduce obesity, nor, as Beauchamp implies, have we said so. Beauchamp cites an article on a study of promotion of physical activ- ity in high-school girls; in that study, effects were observed on activity levels, not obesity. We strongly advocate physical activity for health and for fighting obesity. As we wrote in our article, There is almost certainly a level of physical ac- tivity (a specific combination of frequency, in- tensity, and duration) that would be effective in reducing or preventing obesity. However, data are lacking from randomized, controlled trials to indicate that level. Krista Casazza, Ph.D., R.D. University of Alabama at Birmingham Birmingham, AL Russell Pate, Ph.D. University of South Carolina Columbia, SC David B. Allison, Ph.D. University of Alabama at Birmingham Birmingham, AL dallison@ms.soph.uab.edu Since publication of his article, Dr. Allison reports receiving grant support through his institution from Kelloggs and states that he may consult on a legal case with a firm that represents Kelloggs. No further potential conflict of interest relevant to this letter was reported. 1. Kramer MS, Fombonne E, Igumnov S, et al. Effects of pro- longed and exclusive breastfeeding on child behavior and mater- nal adjustment: evidence from a large, randomized trial. Pediat- rics 2008;121(3):e435-e440. The New England Journal of Medicine Downloaded from nejm.org on August 4, 2014. For personal use only. No other uses without permission. Copyright 2013 Massachusetts Medical Society. All rights reserved. correspondence n engl j med 368;23 nejm.org june 6, 2013 2237 2. Kramer MS, Matush L, Vanilovich I, et al. Effects of pro- longed and exclusive breastfeeding on child height, weight, adi- posity, and blood pressure at age 6.5 y: evidence from a large randomized trial. Am J Clin Nutr 2007;86:1717-21. 3. Cope MB, Allison DB. Critical review of the World Health Organizations (WHO) 2007 report on evidence of the long-term effects of breastfeeding: systematic reviews and meta-analysis with respect to obesity. Obes Rev 2008;9:594-605. 4. Jiang M, Foster EM. Duration of breastfeeding and child- hood obesity: a generalized propensity score approach. Health Serv Res 2013;48:628-51. 5. Martin RM, Patel R, Kramer MS, et al. Effects of promoting longer-term and exclusive breastfeeding on adiposity and insu- lin-like growth factor-I at age 11.5 years: a randomized trial. JAMA 2013;309:1005-13. DOI: 10.1056/NEJMc1303009 Case 4-2013: A Man with Acute Flank Pain To the Editor: In the Case Record, Greka et al. (Jan. 31 issue) 1 describe a 50-year-old man with flank pain due to renal infarction secondary to bacterial endocarditis, and they report that viri- dans group streptococci are the most common cause of native-valve infective endocarditis in adults. Although this was previously the case, re- sults from the International Collaboration on EndocarditisProspective Cohort Study and other studies 2-4 have shown that the microbiologic char- acteristics of infective endocarditis in adults have changed. Staphylococcus aureus is now the most com- mon bacterial cause in much of the world. This shift from viridans group streptococci probably stems from increases in health careassociated S. aureus bacteremia and subsequent endocarditis. Viridans group streptococci that are sensitive to penicillin (minimum inhibitory concentration, <0.12 g per milliliter) are treated with penicil- lin or ceftriaxone alone. However, experts agree that the treatment of uncomplicated S. aureus bacteremia does not require the addition of an aminoglycoside, since this practice has no proven clinical benefit and may actually increase the risk of nephrotoxicity. 5 Larry M. Bush, M.D. University of Miami Miller School of Medicine Miami, FL drlarry561@aol.com No potential conflict of interest relevant to this letter was re- ported. 1. Case Records of the Massachusetts General Hospital (Case 4-2013). N Engl J Med 2013;368:466-72. 2. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st cen- tury: the International Collaboration on EndocarditisProspec- tive Cohort Study. Arch Intern Med 2009;169:463-73. 3. Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr. Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch Intern Med 2012;172:363-5. 4. Fowler VG Jr, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005; 293:3012-21. [Erratum, JAMA 2005;294:900.] 5. Karchmer AW. Staphylococcus aureus bacteremia and native valve endocarditis: the role of antimicrobial therapy. Infect Dis Clin Pract 2012;20:100-8. DOI: 10.1056/NEJMc1302635 The Discussants and a Colleague Reply: Bush cites the International Collaboration on Endocar- ditisProspective Cohort Study, which involved 2781 adults with definite infective endocarditis who were admitted to 58 hospitals in 25 countries between June 1, 2000, and September 1, 2005. S. aureus was the cause of native-valve endocardi- tis in 31% of the patients, whereas streptococcal species were responsible for this condition in 29%. We agree with Bush that S. aureus is increas- ingly identified as the cause of native-valve endo- carditis. S. aureus and streptococci now account for about equal numbers of cases of native-valve endocarditis, 1 with S. aureus predominating in some studies, as noted by Bush. We also agree that the addition of gentamicin to a semisynthetic antistaphylococcal penicillin or vancomycin is not necessary for treatment of S. aureus bacteremia or native-valve endocarditis. In the patient described in the Case Record, the gentamicin was initially administered in combi- nation with ceftriaxone to treat streptococcal native-valve endocarditis, pending quantitative susceptibility tests. When the organism was found to be fully susceptible to penicillin and ceftriaxone, the gentamicin was discontinued on hospital discharge (not administered for 2 weeks, as stated in the Case Record). Anna Greka, M.D., Ph.D. John P. Dekker, M.D., Ph.D. Stephen B. Calderwood, M.D. Massachusetts General Hospital Boston, MA Since publication of their article, the authors report no fur- ther potential conflict of interest. 1. Correa de Sa DD, Tleyjeh IM, Anavekar NS, et al. Epidemio- logical trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc 2010;85: 422-6. [Erratum, Mayo Clin Proc 2010;85:772.] DOI: 10.1056/NEJMc1302635 The New England Journal of Medicine Downloaded from nejm.org on August 4, 2014. For personal use only. No other uses without permission. Copyright 2013 Massachusetts Medical Society. All rights reserved.